(Q28199116)

English

Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France

scientific article (publication date: 2004)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France (English)

0 references

1 reference

Jean-Pierre Marissal

1

0 references

Bernard Selke

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2004

0 references

published in

PharmacoEconomics

0 references

volume

22

0 references

issue

10

0 references

page(s)

661-70

0 references

cites work

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Socioeconomic aspects of postacute care for patients with brain infarction in France

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects of long-term oral anticoagulant treatment after myocardial infarction.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic foundations of cost-effectiveness analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence trends of ischemic stroke and transient ischemic attacks in a well-defined French population from 1985 through 1994.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15244491

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00019053-200422100-00004

0 references

Dimensions Publication ID

1049129347

0 references

PubMed publication ID

15244491

0 references

(Q28199116)

Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)